28 September 2026
Africa CDC's Continental Immunisation Strategy 2026-2030 aims to close vaccine coverage gaps, fix financing and boost local manufacturing.
2 June 2026
SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement.
19 May 2026
Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa's local manufacturing goals.
13 May 2026
Biovac's expansion funding in Africa hits $128m after a $20m French finance commitment, with the full $180m target due by the end of May.
21 April 2026
Biovac secures major funding for African vaccine manufacturing. The expansion is supported with funds from the EIB and IFC.
12 November 2025
Discover the significance of the cholera vaccine trial by Biovac and the MRC in promoting health self-reliance in Africa.
10 November 2025
Biovac R&D Lab opens in Cape Town, enhancing vaccine manufacturing capabilities for Africa with support from the Gates Foundation.
29 June 2025
Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.